Physician

Jeffrey Michael Shea, M.D.

According to 2025 Medicare claims, Jeffrey Shea, M.D. (NPI: 1972658425) practices pulmonary disease in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is ASSOCIATED CLINICIANS OF EAST TEXAS (NPI: 1932640349; TIN: 352585434) and primary practice location at 75605-2410. Shea is affiliated with the Prime Care Managers, LLC (ACO ID: A3280), participating under the MSSP model.

Shea's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,069 traditional Medicare patients, billed 5,595 HCPCS/CPT codes, and received $364,108 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,213 prescription claims across 445 beneficiaries totaling $1,197,965 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 4,812 claims. Open Payments data shows 48 records totaling $10,508. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $668,872 to $1,197,965. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $393,942 and ending at $249,671.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	896	5,566	$388,430
2016	870	4,859	$339,096
2017	684	3,005	$211,262
2018	566	2,137	$149,282
2019	710	4,730	$293,702
2020	776	5,192	$321,686
2021	800	4,995	$322,222
2022	811	5,438	$289,657
2023	945	5,326	$316,593
2024	1,069	5,595	$364,108

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	377	2,659	$668,872
2016	366	2,726	$890,892
2017	323	2,348	$902,623
2018	243	1,076	$722,227
2019	269	1,464	$1,122,386
2020	346	1,945	$1,830,266
2021	354	1,901	$2,392,187
2022	386	1,998	$2,444,288
2023	477	2,346	$1,615,333
2024	445	2,213	$1,197,965

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,878	5,113	$519,180
2016	1,635	4,610	$366,643
2017	1,320	3,737	$298,497
2018	970	2,393	$199,274
2019	1,165	3,160	$342,198
2020	1,819	4,958	$521,198
2021	1,793	5,212	$572,723
2022	1,768	5,325	$577,396
2023	1,907	5,834	$625,889
2024	1,593	4,812	$453,442

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	399	607	$94
94729	Test to examine how well the lungs exchange gases	267	286	$38
94060	Test to measure expiratory airflow and volume changes before and after medication administration	280	308	$27
71046	X-ray of chest, 2 views	346	438	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	413	656	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	317	11,400	$233,678
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	312	10,410	$160,006
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	230	10,140	$158,678
Ofev	Nintedanib Esylate	13	390	$151,288
Pirfenidone	Pirfenidone	31	930	$146,717

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	38	214	$163,919
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	72	$73,267
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	64	460	$37,219
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	46	240	$36,216
A7030	Full face mask used with positive airway pressure device, each	N	86	195	$15,803

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$830	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$9,677	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Michael Shea, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Michael Shea, M.D. (NPI 1972658425), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Michael Shea, M.D. have ACO affiliation data?

Jeffrey Michael Shea, M.D. is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280).

What billing organization is linked to Jeffrey Michael Shea, M.D.?

Jeffrey Michael Shea, M.D. is linked to ASSOCIATED CLINICIANS OF EAST TEXAS (billing NPI 1932640349) in the available physician profile data.

Does Jeffrey Michael Shea, M.D. have Open Payments data?

Jeffrey Michael Shea, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.